Abstract
This work analyses the consequences of random and systematic dose differences in the comparison of calculated against measured planar dose distributions for IMRT from the perspective of a surrogate of the treatment outcome: Equivalent Uniform Dose (EUD). In‐house software was developed to incorporate normally distributed errors in the fluence maps of 3 head and neck (H&N) and 3 prostate plans and simulate dose differences that appear randomly across the planar dose maps. The plans with random errors were grouped according to the following passing rates: 1) 90–95%, 2)85–90% and 3)80–85% during patient specific quality control. The passing criteria included a 3% absolute dose, 3 mm distance to agreement (DTA), and a minimum dose difference of 2 cGy. A systematic 1% dose error could also be incorporated by altering the MUs of each plan with random errors. The impact of random errors on the prescribed EUDs of H&N plans ranged from −2.7 to −1.3% for the CTV and −1.0 to 0.6 Gy for the OARs while in prostate plans they ranged from −1.6 to −0.6% for the CTV and −1.2 to −0.4 Gy for the OARs over the range examined. The criterion of 90% passing rate for 3% absolute dose and 3 mm DTA kept the effects of random errors within a dosimetric goal of 2% change in prescribed EUDs of the targets and 2 Gy for the OARs. Systematic errors, if present, may cause larger effects on clinical dosimetry while still meeting patient specific quality control tolerances.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have